Novo Nordisk launches medicine at starting price of ₹2,200 a week Ozempic adds to India's growing appetite for anti-obesity drugs

ELI LILLY'S MOUNJARO, which has taken an early lead since its March launch in India, now faces serious competition.

- FE BUREAU

Novo Nordisk on Friday introduced Ozempic, pricing the 0.25 mg starter dose at ₹2,200 per week.For a four-week course, the entry dose works out to ₹8,800, placing the drug firmly in the premium segment of India’s fast-growing obesity and metabolic-health market. By comparison, Mounjaro is priced at ₹14,000 a month for the 2.5 mg initiating dose and rises to ₹27,500 for the 15 mg strength.